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T
he elegantly stacked cisternae of 
the Golgi are central to secretory 
protein maturation and traffi  cking. 
Graham Warren has made it his life’s 
work to demystify the biology of this 
essential organelle.
Trained as a classical biochemist 
in England, Warren took a position as 
group leader at the then newly estab-
lished European Molecular Biology 
Laboratory (EMBL). There, he studied 
protein traffi  cking through the Golgi (1) 
and pioneered the use of cell-free methods 
to study other membrane traffi  cking 
processes. Later professorships in Scot-
land (2), England (3), and the United 
States (4) saw Warren applying these 
methods to how the Golgi fragments 
and disperses between daughter cells 
during mitosis.
Warren is now serving as Director 
of the Max F. Perutz Laboratories in Vi-
enna, Austria. Meanwhile, his research 
continues to focus on Golgi inheritance, 
but he now uses the parasitic 
protozoan  Trypanosoma 
brucei as a model system 
to probe this process (5, 6). 
We called him up to have 
him break down his career 
for us.
THE RIGHT CHEMISTRY
You were born in postwar England, is 
that right?
Yes, I was born and brought up in London. 
I came from a working class part of the 
city. My father was a carpenter, and be-
cause we were quite poor, my mother 
worked various factory jobs to help 
support the family. I was actually the fi  rst 
person in my family ever to go to college. 
During those postwar days, places like 
Oxford and Cambridge were opening up 
and becoming more meritocratic rather 
than class based, so I went to Cambridge, 
where I won a scholarship. That was an 
important opportunity for me. Being born 
at the right time always helps.
What else was special about growing up 
at that time?
Oh, it was a very different time. In chem-
istry classes, I remember gathering 
around a desk with my classmates to 
watch the teacher drop a lump of sodium 
into a bowl of water—and see it skim-
ming across the surface of the water. But 
I imagine that this might not be done as 
much in schools these days because it’s 
potentially dangerous. And I had inter-
ests that I suspect not many children 
are able to pursue these days: growing 
up, I had my own chemistry laboratory, 
and I loved to make things like transistor 
radios. Of course, it’s not really possible 
to make a radio with off-the-shelf com-
ponents these days; things are far too 
miniaturized and complicated.
You had your own chemistry laboratory 
as a child?
My chemistry teacher had an incentive 
for us, which was that if you were one 
of the top three students 
in the class, he would sign 
orders that you could take 
to a big chemical supplier 
and buy chemicals and 
equipment to experiment 
with at home. You’d make 
a list of the items you 
wanted to buy, which the teacher would 
have to approve. Then you’d save up 
your pocket money and take your signed 
order to the tradesmen’s entrance at the 
supplier’s. Of course, it was always a 
kind of game to try to sneak in things 
that you knew would explode if you 
mixed them together. But the teacher 
would always catch us and cut those off 
the list.
I think things like this have been 
lost, largely because of safety issues. 
That’s a shame in my view, because 
this was how I personally got inter-
ested in science, and I don’t know how 
many children have opportunities like 
that anymore.
BIOCHEMIST’S APPROACH
How did your initial interest in 
chemistry affect your later choices?
Well, I always knew I wanted to be a scien-
tist, and it so happened that Cambridge was 
a great place to pursue that. Several of my 
undergraduate lectures, for example, were 
given by Fred Sanger on protein sequenc-
ing. Having the person who invented the 
method give you the lecture on it was 
really quite amazing, I have to say. Enzyme 
kinetics at that time was considered the 
subject to do, and it was a very exciting time 
to do it. That’s why I was a biochemist 
initially. Later I became more of a molecu-
lar cell biologist, but coming from a 
biochemical angle, which means I believe 
everything should be quantitated.
You stayed on at Cambridge for your 
PhD and postdoc?
Yes, but I hadn’t planned it that way. I’d 
actually gone to London for my postdoc, 
but then ended up back in Cambridge 
when my supervisor got a position there. 
So I was there for another two years before 
heading off to EMBL at Heidelberg, 
which was exciting because the institute 
was just getting started then.
Warren’s studies of the Golgi have yielded a rich trove of insights.
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As a new investigator at EMBL, did you 
have any training in how to run your 
own laboratory?
At EMBL, Kai Simons was the program 
coordinator in the cell biology program, 
which turned out to be crucial for me. He 
was my mentor. He was the one who 
taught me how to focus on problems, and 
he generally guided and encouraged me, 
but also let me go my own direction. I had 
this great feeling of being independent, 
but also of being looked after. This is 
something I’ve tried to pass on to those 
who’ve worked with me: I like to foster a 
sense of scientifi  c independence early on.
What do you mean by “scientiﬁ  c 
independence”?
I think it’s important for people to take 
ownership of their work. For instance, 
one thing I am rather strict about is the 
authorship of papers. I strongly feel that 
the person who did the work should be the 
one who gets credit for it. I shouldn’t be 
on a paper if I only contributed reagents 
or grant money. A pragmatic test of this is 
whether I understand it well enough to 
present it at a major meeting.
How did you get interested in trying to 
understand the Golgi?
My postdoctoral work was on membranes. 
I’d always been interested in the Golgi—
it’s such a beautiful, elegant 
looking thing, really. But it 
was actually at EMBL, on 
Kai’s suggestion, that I got 
into looking at the passage of 
viral membrane proteins 
through the cell. These pro-
teins are made in the ER and 
end up on the plasma mem-
brane, but at the time we didn’t 
know how they got there—for 
all we knew, they might skip 
the Golgi altogether. One of 
the fi  rst things we did in my 
own laboratory was to actually look at 
this process and show that membrane pro-
teins go from the ER to the Golgi to the 
plasma membrane. It sounds trivial now, 
but at that time it was quite an important 
step to show that membrane proteins all 
followed the same 
pathway as did soluble 
secretory proteins.
BREAKING IT 
DOWN
But eventually you 
became interested in 
what happens to the 
Golgi in mitosis?
Our EMBL colleagues 
had made an antibody 
against mannosidase II, 
which visualizes whole 
Golgi, and we saw that 
if you looked at the 
Golgi of most inter-
phase cells, you’d see 
the nucleus and this 
nice Golgi ribbon next to it. But if you 
looked at cells undergoing mitosis, the 
Golgi would virtually disappear—it com-
pletely fragments—and is later reassem-
bled in each daughter cell after mitosis. I 
saw there was essentially no literature on 
this, so I decided to look into it. At this 
time, no one knew about COPI vesicles 
and things like that, but we eventually came 
up with the idea that what happens during 
mitosis is that vesicles keep budding off the 
Golgi as part of the normal process of pro-
tein transport, but they can no longer fuse, 
leading to the Golgi’s disintegration.
Why did you recently move 
to studying Golgi duplication 
in trypanosomes?
Much of my work has been 
done in mammalian cells. But 
the trouble with a mammalian 
cell is that it has 100 copies of 
the Golgi that become 200 
copies during mitosis. All of 
them are stitched together into 
one huge ribbon, so you really 
can’t follow what’s going on. 
In trypanosomes, you just have 
one Golgi and you can actually watch it 
duplicate using GFP-tagged proteins. And, 
because the organism is genetically tractable 
and the genome completely sequenced, you 
can also do all the normal experiments like 
mutating candidate genes, RNAi, and so on.
We recently discovered this new 
structure that we call a bilobe. It seems 
to be a scaffold that designates where 
the new Golgi grows during the cell 
cycle. We’re now trying to explore its 
composition, and what function it has 
in cells. We’re taking the biochemist’s 
approach, again: pick it apart and see 
how it works.
Let’s pick apart your career: you’ve 
moved around a lot, haven’t you?
I always try to tell people it’s good to 
move every ten years or so, because you 
just don’t realize how comfortable you 
become where you are. When you’re sud-
denly thrown into a new environment it 
can jog your thinking out of any rut you 
might have been in. But perhaps I am 
done with moving now. I’m Director here 
at the Max Perutz, and the two universi-
ties here have set me up with a very nice 
package of funding for junior group leaders. 
We’re bringing in new people with great 
ideas. It’s very exciting.
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The Golgi has captured Warren’s imagination, inspiring an 
artistic rendition.
“I strongly 
feel that the 
person who 
did the work 
should be 
the one who 
gets credit 
for it.”